abstract / Biochemistry / Doctoral / Doctor of Philosophy

Not available / text

Not available / text

Not available / text

Not available / text

In addressing the pre-mRNA substrate, the splicing machinery requires rearrangement of multiple RNA and protein components. The classical model of spliceosome formation begins with the U1 snRNA recognition of the 5" splice site and U2 snRNP interaction with the branch point. This process is followed by the engagement of a pre-assembled U4/U6·U5 tri-snRNP to form the A2-1 complex. The spliceosome is subsequently activated through a number of structural rearrangements. Among these is the unwinding of the U4/U6 intermolecular helix by the tri-snRNP component Brr2p. While numerous protein components of the tri-snRNP have been identified, the function of many of these remain unknown. The nonessential Snu66p (U4/U6·U5-110K in humans) stably associates only with the U4/U6·U5 tri-snRNP while the similarly nonessential Snu40p (U5-52K in humans) associates exclusively with the U5 snRNP. To understand why two non-essential pre-mRNA splicing factors have been so well conserved through great evolutionary distances, we examined their roles in the assembly and function of the tri-snRNP. Removal of SNU40 alone does not affect snRNP levels, however deletion of SNU66 results in reduced levels of tri-snRNP. The U4/U6·U5 snRNPs in [Delta]snu66 cells are resistant to the ATP-dependent U4/U6 unwinding by Brr2p, and profound U4/U6 accumulation occurs at reduced temperatures. Remarkably, subsequent removal of SNU40 in a [Delta]snu66 strain bypasses the tri-snRNP formation defect while unwinding of U4/U6 remains defective. Additional investigation revealed that Prp6p, another tri-snRNP protein, is destabilized from the complex. Based upon this data in total, I present a model in which Snu40p and Snu66p interact sequentially with Prp6p to maintain directionality for proper biogenesis of the tri-snRNP. Further, the U4/U6 unwinding defect of the double mutant should theoretically arrest the A2-1 spliceosome. Indeed, native gel analysis confirms the buildup of a large complex later determined to be A2-1. I have purified this complex, functionally tested its catalytic viability, and identified its components via mass spectrometry. This is the first full characterization of the A2-1 precatalytic spliceosome complex in Saccharomyces cerevisiae. / text

Not available / text

A hormone response element and a negative regulatory element upstream of the human insulin gene have been investigated. The hormone response element is located one kilobase upstream of the transcription start site. When isolated and placed upstream of a viral promoter, it has been found to increase transcription in response to retinoic acid and thyroid hormone. It is also able to mediate a transcriptional response to retinoic acid, and to the retinoic acid receptor in the context of the entire insulin gene promoter/enhancer region. This element is able to bind to members of the retinoid receptor family in vitro. Insulin gene transcription in isolated human islets of Langerhans was also shown to be upregulated by retinoic acid. The negative regulatory element within the human insulin gene enhancer lies between 279 and 258 base pairs upstream of the transcription start site, although it relies upon nearby insulin enhancer sequence in order to act upon a heterologous promoter. The transcriptional silencing properties of the negative element can be abolished by point mutations of critical residues. The element forms several complexes with nuclear proteins from an insulin producing cell line, one of which is related to the ubiquitous POU domain factor, Oct-1. The relevance of these findings to the control of insulin gene transcription is discussed.

No description available.

The yeast Fus1p SH3 domain recognizes non-PXXP motif targets. This is contrary to most SH3 domains, which recognize PXXP-containing sequences. In this thesis, I characterized atypical binding of the Fus1p SH3 domain and provide insight into atypical SH3 domain interactions. I demonstrated that the Fus1p SH3 domain binds R(S/T)(S/T)SL-containing peptides derived from yeast proteins, Bnr1p and Ste5p. Through mutagenesis studies and comparisons to other SH3 domains, I showed that the Fus1p SH3 domain utilizes a portion of the same binding surface as typical SH3 domains. However, the PXXP-binding surface is debilitated in the WT domain by the substitution of unusual residues at three key conserved positions. By replacing these residues, I created a version of the Fus1p SH3 domain that binds a PXXP-containing peptide with extremely high affinity. Based on my data and analysis, I clearly delineated two distinct surfaces comprising the typical SH3 domain binding interface, and show that one of these surfaces is the primary mediator of almost every “non-canonical” SH3 domain-mediated interaction. I demonstrated that the Fus1p SH3 domain also binds Bni1p and Pea2p through yeast two-hybrid experiments, which do not contain either PXXP or R(S/T)(S/T)SL motifs. Through mutagenesis studies and two-hybrid experiments, I showed that the Fus1p SH3 domain utilizes a binding surface comprised of two sub-surfaces to interact with Bni1p and Pea2p. The sub-surfaces include the same portion of the binding surface in typical SH3 domains utilized in R(S/T)(S/T)SL binding of the Fus1p SH3 domain, and a novel binding site. I also showed that the protein binding surface of the Fus1p SH3 domain has a role(s) for efficient mating. Based on my findings in this thesis, I propose that dramatic alterations in SH3 domain specificity can be simply explained as a modulation of the binding strengths of sub-binding sites within the binding surface.